US Pharma MarketingNew home for Novo
Novo Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing: The push for in vivo therapies Drug pricing and the IRA: Tracking the government's negotiation power FDA policy and drug approvals: What’s changing…
Plus, label expansions for two drugs targeting rare diseases, and Genmab scraps a Phase 1 cancer trial:
🧠 Novo's Parkinson's cell therapy finds a biotech home: Novo Nordisk has found a home for an early-stage ...
Source: Endpoints News